Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics appear as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T06:49:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:42:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and potential information delays was added. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:30:17.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:42:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, a minor technical update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:31:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a Texas location under Locations and updated the revision to v3.3.3. Removed footer/related entries for HHS Vulnerability Disclosure, MedlinePlus Genetics, and Texas Locations.
    Difference
    0.4%
    Check dated 2025-12-30T16:32:41.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.